JUBLPHARMA — Jubilant Pharmova Share News
0.000.00%
- IN₹152.72bn
- IN₹174.03bn
- IN₹82.80bn
India's Jubilant Pharmova soars to 3 yr-high on upbeat Q1 results
India's Jubilant Pharmova falls on likely US FDA violations
Brief: Jubilant Pharmova Announces Completion Of USFDA Audit Of Contract Manufacturing Facility In Canada
Brief: Jubilant Pharmova's Unit Announced An Investment Of $50 Million To Expand Pet Radiopharmacy Network
India's Jubilant Pharmova falls after USFDA issues observations on Washington unit
Brief: Jubilant Pharmova Announces Completion Of USFDA Audit Of Contract Manufacturing Facility At Spokane, Washington
India's Jubilant Pharmova reports narrower fourth-quarter loss
Brief: Jubilant Pharmova Says Unit To Enter Into Power Supply And Offtake Agreement With Isharays Energy Two
Brief: Jubilant Pharmova Says Tax Demand Of 1.9 Billion Rupees Stands Deleted In Its Entirety
India's Jubilant Pharmova climbs to near 3-year high after Roorkee facility gets FDA nod
Brief: Jubilant Pharmova Says USFDA Determines Inspection Classification Of 'Voluntary Action Indicated' For Roorkee Facility
India's Jubilant Pharmova posts quarterly profit
India's Jubilant Pharmova rises after unit gets US FDA approval
India's Jubilant Pharmova surges on Q2 profit jump
Brief: India's Jubilant Pharmova Ltd Sept-Quarter Consol Net Profit Rises
Domino's India franchisee beats Q2 profit estimates as cheaper pizzas help demand (updated)
Domino's India operator Jubilant beats Q2 profit estimates on cheaper launches
India's Jubilant Pharmova slides most in over 15 months
India's Jubilant Pharmova falls on lower Q1 profit